These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6450905)

  • 1. Dexamethasone suppression test in the management of hyperandrogenized patients.
    Abraham GE; Maroulis GB; Boyers SP; Buster JE; Magyar DM; Elsner CW
    Obstet Gynecol; 1981 Feb; 57(2):158-65. PubMed ID: 6450905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of dexamethasone on serum cortisol and androgen levels in hirsute patients.
    Abraham GE; Maroulis GB; Buster JE; Chang RJ; Marshall JR
    Obstet Gynecol; 1976 Apr; 47(4):395-402. PubMed ID: 130572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen excess in women with acne.
    Scholl GM; Wu CH; Leyden J
    Obstet Gynecol; 1984 Nov; 64(5):683-8. PubMed ID: 6238252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prolonged remission of female hyperandrogenism after discontinuing glucocorticoid therapy].
    Devoto E; Aravena L; Gaete X
    Rev Med Chil; 1995 Feb; 123(2):207-14. PubMed ID: 7569461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testosterone, dehydroepiandrosterone, and dehydroepiandrosterone sulfate in hyperandrogenic women.
    Steinberger E; Smith KD; Rodriguez-Rigau LJ
    J Clin Endocrinol Metab; 1984 Sep; 59(3):471-7. PubMed ID: 6235239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity of cortisol and adrenal androgens to dexamethasone suppression in hirsute women.
    Rittmaster RS; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1985 Sep; 61(3):462-6. PubMed ID: 2991319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Critical study of the characterization of hyperandrogenism in a group of obese women].
    Cordray JP; Merceron RE; Nys P; Guillerd X; Reboul P; Rainaut M
    Rev Fr Gynecol Obstet; 1995 Oct; 90(10):403-8. PubMed ID: 8539505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral contraceptive therapy for polycystic ovary disease after chronic gonadotropin-releasing agonist administration. Predictors of continued ovarian suppression.
    Elkind-Hirsch KE; Anania C; Malinak R
    J Reprod Med; 1996 Sep; 41(9):645-52. PubMed ID: 8887188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sequential analysis of the prolonged dexamethasone suppression test in patients with hirsutism].
    de Moraes CR; Kater CE
    AMB Rev Assoc Med Bras; 1988; 34(6):184-9. PubMed ID: 2855277
    [No Abstract]   [Full Text] [Related]  

  • 10. Diagnosis of hyperandrogenism: biochemical criteria.
    Stanczyk FZ
    Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):177-91. PubMed ID: 16772150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
    Kazerooni T; Dehghan-Kooshkghazi M
    Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dexamethasone and clomiphene citrate on peripheral steroid levels and ovarian function in a hirsute amenorrheic patient.
    Chang RJ; Abraham GE
    Fertil Steril; 1976 Jun; 27(6):640-6. PubMed ID: 132375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential adrenal and ovarian suppression. Diagnosis and treatment of androgenic disorders in women.
    Cruikshank DP; Chapler FK; Yannone ME
    Obstet Gynecol; 1971 Nov; 38(5):724-30. PubMed ID: 4255920
    [No Abstract]   [Full Text] [Related]  

  • 14. [Strategies in screening of nonclassical forms of congenital adrenal hyperplasia caused by P450c21 deficiency in hyperandrogenic women].
    Rodríguez Espinosa J; Calaf Alsina J
    Med Clin (Barc); 1994 Nov; 103(17):645-51. PubMed ID: 7808062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyproterone acetate-ethinyl estradiol treatment alters urinary 6-sulfatoxymelatonin excretion in hyperandrogenic women.
    Luboshitzky R; Herer P; Shen-Orr Z
    Neuro Endocrinol Lett; 2002 Aug; 23(4):309-13. PubMed ID: 12195232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women.
    Kaltsas GA; Isidori AM; Kola BP; Skelly RH; Chew SL; Jenkins PJ; Monson JP; Grossman AB; Besser GM
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2634-43. PubMed ID: 12788867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combined clomiphene-dexamethasone therapy in cases with resistance to clomiphene (author's transl)].
    Lisse K
    Zentralbl Gynakol; 1980; 102(12):645-50. PubMed ID: 7445819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic and therapeutic use of dexamethasone suppression in some cases of hirsutism with elevated plasma testosterone (author's transl)].
    Zanno C; Zagami L; Terzi I
    Ann Osp Maria Vittoria Torino; 1980; 23(7-12):428-34. PubMed ID: 7316352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative evaluation of the androgenicity of four low-dose, fixed-combination oral contraceptives.
    Coenen CM; Thomas CM; Borm GF; Rolland R
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():92-7. PubMed ID: 8574256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnostic strategy in infertility due to hyperandrogenism. Development of a decision tree].
    Cordray JP; Merceron RE; Siboulet B; Guillerd X; Nys P; Reboul P; Rainaut M
    Rev Fr Gynecol Obstet; 1994 May; 89(5):245-54. PubMed ID: 8036386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.